Karuna Therapeutics Stock Price Chart

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KRTX is experiencing selling pressure, which indicates risk of future bearish movement.

Karuna Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 183.55 Buy
20-day SMA: 177.5 Buy
50-day SMA: 172.89 Buy
200-day SMA: 193.24 Sell
8-day EMA: 184.39 Buy
20-day EMA: 179.15 Buy
50-day EMA: 177.31 Buy
200-day EMA: 187.3 Sell

Karuna Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.17 Buy
Relative Strength Index (14 RSI): 56.98 Buy
Chaikin Money Flow: -72786 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (166.84 - 183.58) Buy
Bollinger Bands (100): (167.93 - 194.19) Buy

Karuna Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Karuna Therapeutics Stock

Is Karuna Therapeutics Stock a Buy?

KRTX Technical Analysis vs Fundamental Analysis

Karuna Therapeutics (KRTX) is a Buy

Is Karuna Therapeutics a Buy or a Sell?

Karuna Therapeutics Stock Info

Market Cap:
Price in USD:
Share Volume:

Karuna Therapeutics 52-Week Range

52-Week High:
52-Week Low:
Karuna Therapeutics (KRTX) is a Buy

Karuna Therapeutics Share Price Forecast

Is Karuna Therapeutics Stock a Buy?

  • Karuna Therapeutics share price is 185.35 while KRTX 8-day exponential moving average is 184.39, which is a Buy signal.
  • The stock price of KRTX is 185.35 while Karuna Therapeutics 20-day EMA is 179.15, which makes it a Buy.
  • Karuna Therapeutics 50-day exponential moving average is 177.31 while KRTX share price is 185.35, making it a Buy technically.
  • KRTX stock price is 185.35 and Karuna Therapeutics 200-day simple moving average is 187.30, creating a Sell signal.

Fundamental Analysis of Karuna Therapeutics

Is Karuna Therapeutics a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.18 per share, and an increase next year of $0.14 per share.

Technical Analysis of Karuna Therapeutics

Should I short Karuna Therapeutics stock?

* Karuna Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.